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Unfortunately, the online published article has errors in Table 1. The correct table is given below. 
Table 1  Summary of demographic details, signature pathology, associated pathology, and diagnostic criteria in the disorders studied 
 
Disorder N Mean age (SD) M:F Signature lesion Additional pathology Diagnostic criteria 
AD 20 76 (13.0) 5:15 Ab deposits NFT EN, GVC NINCDS/ADRDA/CERAD 
sCJD 11 67 (8.5) 6:6 PrPsc  deposits Vacuolation Budka et al. (1995) 
vCJD 11 29 (9.1) 5:6 PrPsc  deposits Vacuolation Ironside et al. (2000) 
DS 12 51 (9.7) 6:6 Ab deposits NFT By karyotype 
PD-Dem 15 75 (5.0) 12:3 LB LN, LG UKPDSBB 
PiD 10 65.3 (11.3) 7:3 PB NFT, PC Cairns et al. (2007) 
CBD 12 64.7 (9.07) 8:4 NCI AP, GI, EN NIH-ORD 
PSP 8 73.4 (7.4) 4:4 NFT TA, GI, NP NINDS-SPSP 
DLB 12 73.8 (7.2) 12:0 LB DN CDLB 
MSA 10 66.5 (8.51) 7:3 GCI NCI MCC 
NIFID 10 45.3 (12.1) 7:3 NCI GI, DN Cairns et al. (2007) 
FTLD-TDP 15 69.6 (8.50) 7:2 NCI NII, DN, GI Cairns et al. (2007) 
 
Diagnostic criteria: ‘National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer Disease and Related 
Disorders Association’ (NINCDS/ADRDA) (Tierney et al. 1988), ‘Consortium to Establish a Registry of Alzheimer Disease’ (CERAD) criteria 
(Mirra et al. 1991); United Kingdom Parkinson Disease Society Brain Bank clinical diagnostic criteria (UKPDSBB); National Institute of 
Health-Office of rare disorders (NIH-ORD); National Institute of Neurological Disorders and Stroke (NINDS) and the Society of PSP (SPSP) 
(NINDS-SPSP) (Hauw et al. 1994; Litvan et al. 1996a, b); ‘Consortium on Dementia with Lewy bodies’ (CDLB)’ (McKeith et al. 1996); 
‘Minneapolis Consensus Criteria (MCC) (Gilman et al. 1998); diagnostic criteria for PiD, NIFID (FTLD-FUS) and FTLD-TDP according to Cairns 
et al. (2007) 
Disorders: AD Alzheimer’s disease, DS Down’s syndrome, PiD Pick’s disease, CBD corticobasal degeneration, PSP progressive supranuclear 
palsy, DLB dementia with Lewy bodies, MSA multiple system atrophy, NIFID neuronal intermediate filament inclusion disease, FTLD-TDP 
frontotemporal lobar degeneration with TDP-43 proteinopathy, PD-Dem Parkinson’s disease dementia, sCJD sporadic Creutzfeldt–Jakob 
disease, vCJD variant Creutzfeldt–Jakob disease 
Neuropathology: AP astrocytic plaques, DN dystrophic neurites, EN enlarged neurons, GI glial inclusions, GVC granulovacuolar change, LG 
Lewy grains, LN Lewy neurites, NCI neuronal cytoplasmic inclusions, NFT neurofibrillary tangles, NII neuronal internuclear inclusion, PC Pick 
cells 
N number of cases studied, M male, F female, SD standard deviation 
